Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16939817rdf:typepubmed:Citationlld:pubmed
pubmed-article:16939817lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:16939817lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:16939817lifeskim:mentionsumls-concept:C0004561lld:lifeskim
pubmed-article:16939817lifeskim:mentionsumls-concept:C0020204lld:lifeskim
pubmed-article:16939817lifeskim:mentionsumls-concept:C1417753lld:lifeskim
pubmed-article:16939817lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:16939817pubmed:issue9lld:pubmed
pubmed-article:16939817pubmed:dateCreated2006-8-30lld:pubmed
pubmed-article:16939817pubmed:abstractTextNumerous monoclonal antibodies have been developed for the purpose of medical treatments, including cancer treatment. For clinical application, the most useful are human-derived antibodies. In this study, we tried to prepare designed antigen-specific antibodies of completely human origin using immunodeficient mouse.lld:pubmed
pubmed-article:16939817pubmed:languageenglld:pubmed
pubmed-article:16939817pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:citationSubsetIMlld:pubmed
pubmed-article:16939817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16939817pubmed:statusMEDLINElld:pubmed
pubmed-article:16939817pubmed:monthSeplld:pubmed
pubmed-article:16939817pubmed:issn0301-472Xlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:ImaiKohzohKlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:TakiTakaoTlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:ShiinaMasashi...lld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:TamaokiNorika...lld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:TokudaYutakaYlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:ItoMamoruMlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:KatoShunichiSlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:AndoKiyoshiKlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:SaitoYukiYlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:HabuSonokoSlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:IshikawaDaiDlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:MatsumuraTaku...lld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:KametaniYoshi...lld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:ItoRyojiRlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:TsukamotoHide...lld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:KatanoIkumiIlld:pubmed
pubmed-article:16939817pubmed:authorpubmed-author:ToyamaKanaeKlld:pubmed
pubmed-article:16939817pubmed:issnTypePrintlld:pubmed
pubmed-article:16939817pubmed:volume34lld:pubmed
pubmed-article:16939817pubmed:ownerNLMlld:pubmed
pubmed-article:16939817pubmed:authorsCompleteYlld:pubmed
pubmed-article:16939817pubmed:pagination1240-8lld:pubmed
pubmed-article:16939817pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:meshHeadingpubmed-meshheading:16939817...lld:pubmed
pubmed-article:16939817pubmed:year2006lld:pubmed
pubmed-article:16939817pubmed:articleTitleDevelopment of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.lld:pubmed
pubmed-article:16939817pubmed:affiliationDepartment of Immunology, Tokai University School of Medicine, Kanagawa, Japan.lld:pubmed
pubmed-article:16939817pubmed:publicationTypeJournal Articlelld:pubmed